Histrelin Acetate Patents

Given below is the list of patents protecting Histrelin Acetate, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Histrelin Acetate's patents.

Latest Legal Activities on Histrelin Acetate's Patents

Given below is the list recent legal activities going on the following patents of Histrelin Acetate.

Activity	Date	Patent Number
Critical Events This Week
Payment of Maintenance Fee, 12th Year, Large Entity	12 Apr, 2023	US8062652
Payment of Maintenance Fee, 8th Year, Large Entity	11 Apr, 2019	US8062652
Correspondence Address Change Critical	09 Aug, 2012	US8062652
Change in Power of Attorney (May Include Associate POA) Critical	09 Aug, 2012	US8062652
Post Issue Communication - Certificate of Correction	24 Apr, 2012	US8062652
Patent Issue Date Used in PTA Calculation Critical	22 Nov, 2011	US8062652
Recordation of Patent Grant Mailed Critical	22 Nov, 2011	US8062652
Issue Notification Mailed Critical	02 Nov, 2011	US8062652
Dispatch to FDC	20 Oct, 2011	US8062652
Miscellaneous Incoming Letter	11 Oct, 2011	US8062652

Histrelin Acetate's Family Patents

Full family tree

Explore Our Curated Drug Screens